Secukinumab Therapy for the Treatment of Moderate to Severe Plaque Psoriasis With Response Monitoring Using Optical Coherence Tomography (OCT).
Clinical trial NCT03307447 · UNKNOWN
Trial details
- NCT number
- NCT03307447
- Sponsor
- Narrows Institute for Biomedical Research
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-19
- Primary completion
- 2021-09-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.